BSECompany Update22 Jun 2026 · 22 Jun 2026, 04:09 pm
Outcome of the Rights issue Committee Meeting Held on 22nd June, 2026
Indrayani Biotech Ltd · 526445
✦ AI Summary▼ NegativeFundraise
Indrayani Biotech Ltd has announced the indefinite postponement of its partly paid-up Rights Issue. The Rights Issue Committee, at its meeting on June 22, 2026, decided to defer the schedule until further notice, which was previously extended to close on July 24, 2026. While the revised opening and closing dates will be intimated later, the offer price and rights entitlement ratio approved earlier will remain unchanged.
Analysis Scores
Earnings Impact4/10
Growth Catalyst3/10
Governance Concern4/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact5/10
Market Sentiment3/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indrayani Biotech Ltd - 526445 - Outcome Of The Rights Issue Committee Meeting Held On 22Nd June, 2026
Attachments (1)
📄pdf
Download →
09dc0e69-b516-4313-858c-66063b7337fb.pdf
View document text
IBL Indrayani
Date: June 22, 2026
Listing Operations Department, )
BSE Limited, -
P.J. Towers,
Dalal Street, Mumbai — 400 001.
Scrip ID: 526445
ISIN: INE007C01021
Subject: Outcome of the Rights Issue Committee - ("'Committee') of Indrayani Biotech Limited
""Company") for Postponement of Rights issue schedule.
Dear Sir/Madam,
This outcome is in continuation of the earlier outcomes dated April 09, 2026 and May 25, 2026, wherein the issue
schedule and other terms and conditions relating to Rights issue were finalised
This is to inform the eligible equity shareholders of the Company that the Rights Issue Committee, at its meeting
held on June 22, 2026, has decided to postpone the schedule of the partly paid-up Rights Issue.
The Rights Issue schedule, which was initially scheduled to open on Wednesday, May 27, 2026 and close on
Thursday, June 25, 2026, and was subsequently extended from Thursday, June 25, 2026 to Friday, July 24, 2026,
stands postponed until further notice.
The revised issue opening and closing dates shall be intimated separately once finalized by the Rights Issue
Committee.
Further, the terms relating to the offer price and rights entitlement ratio will remain the same as approved by the
Rights Issue Committee and intimated to the stock exchange earlier.
The updated issue documents shall be made available on the website of the Stock Exchange at www.bseindia.com
and on the website of the Company at www.indrayani.com upon finalization of the revised issue schedule.
We request you to take the above on record and that the same be treated as compliance under the applicable
regulation(s) under the SEBI Listing Regulations.
The meeting commenced at 3.30 PM and concluded at 3.55 PM
You are requested to take the above on record and acknowledge.
Thanks & Regards,
For Indrayani Biotech Limited
Swaminathan. G
‘Wholetime Director
DIN: 02481041
IDCO Electronics Complex, Thiru Vi Ka Industrial Estate, Guindy, Chennai 600032
91-44-24463751 / 22502146 www.indraya ndrayani.com CIN 29301